Anadys Shares Jump Following Hepatitis C Drug Trial
Shares in Anadys Pharmaceuticals rose 28 percent following the announcement of promising results in a clinical trial of its experimental hepatitis C drug ANA773.
sciclone pharmaceuticals
Copyright © 2024 | WordPress Theme by MH Themes